Tyler-Stone Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-72
| Closed | -$4.67K | – | 721 |
|
|
2024
Q2 | $4.67K | Hold |
72
| – | – | ﹤0.01% | 751 |
|
|
2024
Q1 | $4.66K | Hold |
72
| – | – | ﹤0.01% | 741 |
|
|
2023
Q4 | $4.74K | Hold |
72
| – | – | ﹤0.01% | 718 |
|
|
2023
Q3 | $4K | Hold |
72
| – | – | ﹤0.01% | 733 |
|
|
2023
Q2 | $4K | Buy |
+72
| New | +$4K | ﹤0.01% | 724 |
|
|
2022
Q4 | $5K | Hold |
72
| – | – | ﹤0.01% | 653 |
|
|
2022
Q3 | $4K | Hold |
72
| – | – | ﹤0.01% | 674 |
|
|
2022
Q2 | $4K | Hold |
72
| – | – | ﹤0.01% | 693 |
|
|
2022
Q1 | $4K | Hold |
72
| – | – | ﹤0.01% | 694 |
|
|
2021
Q4 | $5K | Buy |
+72
| New | +$5K | ﹤0.01% | 697 |
|